Kory HallettSenior Director, Business Development Search and Evaluation at Otsuka PharmaceuticalsSpeaker
Profile
Kory is Sr. Director for Business Development, Search and Evaluation at Otsuka America Pharmaceutical Inc where she leads efforts to build Otsuka’s rare disease portfolio through external innovation. An immunologist by training with over a decade of experience, Kory’s main focus at Otsuka is therapeutics for rare autoimmune diseases. Prior to Otsuka, Kory spent 8 years at the National Cancer Institute in the Small Business Innovation Research office, a non-dilutive seed investment program to support US startup companies in biotech and pharma.
Agenda Sessions
Investor Panel – Unlocking Rare Disease Investment Success through Valuation, Risk, and Innovation
, 11:30amView Session